Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder.
暂无分享,去创建一个
[1] I A Razak,et al. A national epidemiological survey of oral mucosal lesions in Malaysia. , 1997, Community dentistry and oral epidemiology.
[2] H. Kagan,et al. Reaction pathway of bovine aortic lysyl oxidase. , 1986, The Journal of biological chemistry.
[3] T. Elattar,et al. Cancer and the prostaglandins: a mini review on cancer research. , 1985, Journal of oral pathology.
[4] M. Akagawa,et al. Amine oxidase‐like activity of polyphenols , 2001 .
[5] K. Danø,et al. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. , 1990, The Journal of biological chemistry.
[6] T. Wong,et al. Modulation of lysyl oxidase by dietary copper in rats. , 1996, The Journal of nutrition.
[7] T. Ramasami,et al. Investigations on geometrical features in induced ordering of collagen by small molecules , 2003 .
[8] D. Prockop,et al. Type I procollagen N-proteinase from chick embryo tendons. Purification of a new 500-kDa form of the enzyme and identification of the catalytically active polypeptides. , 1989, The Journal of biological chemistry.
[9] S. J. Chen,et al. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. , 1999, The Journal of investigative dermatology.
[10] H. Kagan,et al. Lysyl oxidase: properties, regulation and multiple functions in biology. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[11] P. Gupta,et al. Malignant transformation rate in oral submucous fibrosis over a 17-year period. , 1985, Community dentistry and oral epidemiology.
[12] P. Gupta,et al. Oral submucous fibrosis as a precancerous condition. , 1984, Scandinavian journal of dental research.
[13] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[14] D J Prockop,et al. Collagens: molecular biology, diseases, and potentials for therapy. , 1995, Annual review of biochemistry.
[15] S. Kunkel,et al. Novel roles for chemokines and fibroblasts in interstitial fibrosis. , 1998, Kidney international.
[16] P. Andreasen,et al. The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.
[17] D. Gomez,et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.
[18] D. Greenspan,et al. Transforming Growth Factor-β Regulation of Bone Morphogenetic Protein-1/Procollagen C-proteinase and Related Proteins in Fibrogenic Cells and Keratinocytes* , 1997, The Journal of Biological Chemistry.
[19] P. Trackman,et al. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[20] T. Axéll,et al. Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[21] W. Stetler-Stevenson,et al. Metalloproteinase Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl Oxidase , 1996, The Journal of Biological Chemistry.
[22] Chien-Jen Chen,et al. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[23] G. Cetta,et al. Protective effect of flavonoids on the collagen of lathyritic rats , 1971, Experientia.
[24] C. Keen,et al. Incorporation of copper into lysyl oxidase. , 1997, The Biochemical journal.
[25] F. Verrecchia,et al. Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach* , 2001, The Journal of Biological Chemistry.
[26] T. Kupper. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. , 1990, The Journal of clinical investigation.
[27] Shun-Fa Yang,et al. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. , 2003, Oral oncology.
[28] P. Gupta,et al. A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. , 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[29] S. Meghji,et al. Oral submucous fibrosis patients have altered levels of cytokine production. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[30] L. Kohn,et al. Procollagen peptidase: an enzyme excising the coordination peptides of procollagen. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[31] Kwan Hw. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. , 1976 .
[32] R. Adar,et al. Type I procollagen C-proteinase from mouse fibroblasts. Purification and demonstration of a 55-kDa enhancer glycoprotein. , 1989, European journal of biochemistry.
[33] A. Ghahary,et al. Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues. , 1993, Journal of Laboratory and Clinical Medicine.
[34] M. Chou,et al. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[35] B. Nusgens,et al. Procollagen type III N-terminal endopeptidase in fibroblast culture. , 1980, The Biochemical journal.
[36] M. Kuo,et al. High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[37] J. J. Pindborg,et al. Oral submucous fibrosis. , 1966, Oral surgery, oral medicine, and oral pathology.
[38] R. Rajendran,et al. An alternative pathogenetic pathway for oral submucous fibrosis (OSMF). , 1989, Medical hypotheses.
[39] L. Chiang,et al. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. , 2003, Oral oncology.
[40] J. Klinman,et al. The Catalytic Function of Bovine Lysyl Oxidase in the Absence of Copper* , 2001, The Journal of Biological Chemistry.
[41] W. Harvey,et al. Oral submucous fibrosis: its pathogenesis and management , 1986, British Dental Journal.
[42] A. Eisen,et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Roberts,et al. Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β* , 1998, The Journal of Biological Chemistry.
[44] H A Seedat,et al. Betel-nut chewing and submucous fibrosis in Durban. , 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[45] Shun-Fa Yang,et al. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. , 2002, Oral oncology.
[46] D. M. Walker,et al. Oral submucous fibrosis. A review. , 1996, Australian dental journal.
[47] W. Harvey,et al. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. , 1986, Archives of oral biology.
[48] V. M. Phillips,et al. Collagen in submucous fibrosis: an electron-microscopic study. , 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[49] N. Oku,et al. Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP. , 2003, Biological & pharmaceutical bulletin.
[50] T. Peters,et al. Raised tissue copper levels in oral submucous fibrosis. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[51] N. Johnson,et al. Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[52] Y. Ho,et al. Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. , 2000, Carcinogenesis.
[53] D. Greenspan,et al. Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinase , 1996, Science.
[54] I. Goldberg,et al. Complex roles of tissue inhibitors of metalloproteinases in cancer , 2002, Oncogene.
[55] B. Klosterhalfen,et al. Modulation of Pro- and Antifibrinolytic Properties of Human Peritoneal Mesothelial Cells by Transforming Growth Factor β1 (TGF- β1), Tumor Necrosis Factor α (TNF-α) and Interleukin β1 (IL-1β) , 1998, Thrombosis and Haemostasis.
[56] L. Liotta,et al. Metalloproteinases and malignant conversion: does correlation imply causality? , 1989, Journal of the National Cancer Institute.
[57] R. DiSilvestro,et al. Evaluation of (+)-catechin action on lysyl oxidase activity in aortic tissue. , 1983, Biochemical pharmacology.
[58] T. Takala,et al. Pre- and Post-translational Regulation of Lysyl Oxidase by Transforming Growth Factor-β1 in Osteoblastic MC3T3-E1 Cells (*) , 1995, The Journal of Biological Chemistry.
[59] M. Djordjevic,et al. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. , 1994, Journal of toxicology and environmental health.
[60] W. Harvey,et al. The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. , 1981, International journal of oral surgery.